Dmitry Balyasny’s Zimmer Biomet ZBH Stock Holding History

Dmitry Balyasny’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-51,500	Closed	-$5.67M	–	1102
2014 Q4	$5.67M	Buy	+51,500	New	+$5.43M	0.05%	407

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Dmitry Balyasny's ZBH Position: Q2 2026 in Review

Dmitry Balyasny sold out of Zimmer Biomet (ZBH) in Q2 2026, closing a stake of 424,578 shares — an estimated $38.4M sold.

Dmitry Balyasny first reported a position in ZBH in Q3 2013 and held it in 40 quarters. The position peaked at $124M in Q3 2022. 904 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Dmitry Balyasny reported no remaining Zimmer Biomet position as of Q2 2026 after selling out during the quarter.
Dmitry Balyasny sold 424,578 Zimmer Biomet shares in Q2 2026, an estimated $38.4M.
Dmitry Balyasny first reported a position in Zimmer Biomet in Q3 2013 and held it in 40 quarters.
Dmitry Balyasny's Zimmer Biomet position peaked at $124M in Q3 2022.
904 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.